Royal Bank Of Canada Regeneron Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 203,197 shares of REGN stock, worth $113 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

203,197

Previous 288,937 29.67%

Holding current value

$113 Million

Previous $206 Million 37.38%

% of portfolio

0.03%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$634.14 - $744.83 $54.4 Million - $63.9 Million	-85,740 Reduced 29.67%	203,197 $129 Million
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $19.3 Million - $28.8 Million	27,497 Added 10.52%	288,937 $206 Million
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $64 Million - $75.1 Million	62,494 Added 31.41%	261,440 $275 Million
Q2 2024 Nov 06, 2024	SELL	$883.2 - $1071.19 $3.48 Million - $4.22 Million	-3,938 Reduced 1.94%	198,946 $209 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $53.2 Million - $64.5 Million	60,190 Added 42.18%	202,884 $213 Million
Q1 2024 Nov 05, 2024	SELL	$902.69 - $993.35 $58.1 Million - $63.9 Million	-64,330 Reduced 31.71%	138,554 $133 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $108 Million - $118 Million	-119,097 Reduced 45.49%	142,694 $137 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $79 Million - $89.8 Million	101,858 Added 63.69%	261,791 $230 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $4.84 Million - $5.9 Million	6,991 Added 4.57%	159,933 $132 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $19.5 Million - $23.2 Million	-27,883 Reduced 15.42%	152,942 $110 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $79.8 Million - $96.9 Million	-117,229 Reduced 39.33%	180,825 $149 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $18 Million - $19.5 Million	-25,495 Reduced 7.88%	298,054 $215 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $7.5 Million - $9.47 Million	-13,074 Reduced 3.88%	323,549 $223 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $12.2 Million - $16.5 Million	22,270 Added 7.08%	336,623 $199 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $21.6 Million - $25.3 Million	36,234 Added 13.03%	314,353 $220 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $44.1 Million - $54.5 Million	81,162 Added 41.21%	278,119 $176 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $55.2 Million - $65.5 Million	96,126 Added 95.33%	196,957 $119 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $47.7 Million - $56.3 Million	100,831 New	100,831 $56.3 Million

Others Institutions Holding REGN

# of Institutions

1,396

Shares Held

87.6M

Call Options Held

1.38M

Put Options Held

1.37M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $59.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Regeneron Pharmaceuticals, Inc. Transaction History